HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hai Wang Selected Research

uK-ATP-1 potassium channel

2/2019SUR2B/Kir6.1 channel openers correct endothelial dysfunction in chronic heart failure via the miR-1-3p/ET-1 pathway.
1/2017Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hai Wang Research Topics

Disease

119Neoplasms (Cancer)
12/2022 - 05/2004
28Breast Neoplasms (Breast Cancer)
01/2021 - 07/2009
28Hypoxia (Hypoxemia)
01/2021 - 02/2003
23Inflammation (Inflammations)
08/2022 - 12/2011
23Neoplasm Metastasis (Metastasis)
01/2022 - 06/2006
16Infections
05/2022 - 07/2008
13Hypertension (High Blood Pressure)
01/2022 - 01/2002
12Prostatic Neoplasms (Prostate Cancer)
01/2022 - 09/2005
10Carcinoma (Carcinomatosis)
01/2021 - 12/2008
8Glioma (Gliomas)
01/2022 - 01/2012
8Fibrosis (Cirrhosis)
01/2022 - 08/2003
8Nasal Polyps (Nasal Polyp)
01/2021 - 02/2016
8Adenocarcinoma
01/2021 - 09/2006
7Necrosis
12/2022 - 11/2004
7Glioblastoma (Glioblastoma Multiforme)
03/2022 - 01/2014
7Acute Kidney Injury (Acute Renal Failure)
01/2022 - 11/2019
7Heart Failure
01/2022 - 08/2009
7Hepatocellular Carcinoma (Hepatoma)
01/2021 - 05/2004
7Vascular Remodeling
11/2005 - 02/2003
6Carcinogenesis
02/2022 - 01/2013
6Polyps
02/2022 - 02/2016
6Sepsis (Septicemia)
01/2021 - 05/2014
6Asthma (Bronchial Asthma)
01/2021 - 02/2017
6Pulmonary Hypertension
01/2014 - 02/2003
5Rhinosinusitis
09/2021 - 01/2018
5Parkinson Disease (Parkinson's Disease)
05/2021 - 05/2005
5Stomach Neoplasms (Stomach Cancer)
03/2021 - 07/2015
5Critical Illness (Critically Ill)
01/2021 - 10/2019
5Nasopharyngeal Carcinoma
12/2016 - 10/2003
5Stroke (Strokes)
01/2016 - 11/2004
5Poisoning
08/2010 - 06/2005
4Rheumatoid Arthritis
05/2022 - 12/2011
4Colorectal Neoplasms (Colorectal Cancer)
02/2022 - 07/2015
4Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 02/2004
4Reperfusion Injury
01/2022 - 01/2007
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 04/2015
4Wounds and Injuries (Trauma)
01/2022 - 05/2012
4Lymphatic Metastasis
03/2021 - 01/2015
4Lung Neoplasms (Lung Cancer)
01/2021 - 12/2008
4COVID-19
01/2021 - 01/2021
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 01/2013
4Proteinuria
09/2020 - 10/2005
4Hyperthermia
10/2019 - 01/2016
4Scoliosis
07/2018 - 09/2008

Drug/Important Bio-Agent (IBA)

43Pharmaceutical PreparationsIBA
01/2022 - 04/2005
37Proteins (Proteins, Gene)FDA Link
03/2022 - 10/2003
24N- (1- methylethyl)- 1,1,2- trimethylpropylamineIBA
10/2021 - 09/2004
19KATP ChannelsIBA
10/2021 - 02/2003
15Adenosine Triphosphate (ATP)IBA
01/2018 - 02/2003
13Biomarkers (Surrogate Marker)IBA
03/2022 - 05/2011
13Messenger RNA (mRNA)IBA
01/2022 - 05/2004
12MicroRNAs (MicroRNA)IBA
12/2021 - 06/2013
10Phosphotransferases (Kinase)IBA
01/2022 - 10/2005
9Biological ProductsIBA
01/2022 - 03/2014
9CytokinesIBA
01/2022 - 01/2016
9Oxygen (Dioxygen)IBA
01/2021 - 09/2004
9Therapeutic UsesIBA
02/2019 - 09/2008
8LipidsIBA
01/2022 - 01/2011
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 10/2005
8ErbB Receptors (EGF Receptor)IBA
01/2017 - 10/2010
7Silicon Dioxide (Silica)FDA LinkGeneric
12/2021 - 01/2014
7EnzymesIBA
01/2021 - 08/2004
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 02/2011
6Small Interfering RNA (siRNA)IBA
01/2022 - 04/2015
6Immunoglobulin E (IgE)IBA
12/2021 - 02/2016
6Interleukin-4 (Interleukin 4)IBA
01/2021 - 02/2016
6Peptides (Polypeptides)IBA
01/2021 - 04/2013
6Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2016 - 08/2003
6Cyclic GMPIBA
06/2009 - 09/2006
5LigandsIBA
03/2022 - 01/2013
5Temozolomide (Temodar)FDA LinkGeneric
03/2022 - 01/2016
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 07/2015
5Glucose (Dextrose)FDA LinkGeneric
09/2021 - 01/2013
5Long Noncoding RNAIBA
05/2021 - 01/2016
5Insulin (Novolin)FDA Link
01/2021 - 06/2009
5Immunoglobulins (Immunoglobulin)IBA
01/2020 - 07/2015
5Folic Acid (Vitamin M)FDA LinkGeneric
10/2019 - 06/2016
5natakalimIBA
02/2019 - 10/2010
5GoldIBA
01/2017 - 04/2013
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 10/2005
5Cholinesterase Inhibitors (Anticholinesterases)IBA
08/2010 - 06/2005
4InterleukinsIBA
05/2022 - 08/2019
4Hormones (Hormone)IBA
01/2022 - 09/2005
4Capsules (Microcapsules)IBA
01/2022 - 02/2016
4Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 02/2015
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2021 - 05/2004
4HydrogelsIBA
10/2021 - 01/2017
4Immunoglobulin G (IgG)IBA
09/2021 - 01/2018
4Estrogen ReceptorsIBA
01/2021 - 08/2011
4Transcription Factors (Transcription Factor)IBA
01/2020 - 02/2016
4ChitosanIBA
06/2019 - 06/2015
4LipopolysaccharidesIBA
11/2018 - 05/2014

Therapy/Procedure

55Therapeutics
01/2022 - 02/2004
23Drug Therapy (Chemotherapy)
01/2020 - 10/2005
8Lasers (Laser)
01/2020 - 11/2014
6Immunotherapy
01/2022 - 02/2004
6Photothermal Therapy
01/2020 - 11/2014
5Intraperitoneal Injections
12/2022 - 11/2009
5Continuous Renal Replacement Therapy
01/2021 - 11/2019
5Radiotherapy
12/2016 - 01/2014